1. Home
  2. MYND vs SNTI Comparison

MYND vs SNTI Comparison

Compare MYND & SNTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MYND
  • SNTI
  • Stock Information
  • Founded
  • MYND 1998
  • SNTI 2016
  • Country
  • MYND United States
  • SNTI United States
  • Employees
  • MYND N/A
  • SNTI N/A
  • Industry
  • MYND Other Consumer Services
  • SNTI Biotechnology: Pharmaceutical Preparations
  • Sector
  • MYND Real Estate
  • SNTI Health Care
  • Exchange
  • MYND Nasdaq
  • SNTI Nasdaq
  • Market Cap
  • MYND 40.6M
  • SNTI 39.6M
  • IPO Year
  • MYND 2017
  • SNTI N/A
  • Fundamental
  • Price
  • MYND $0.91
  • SNTI $1.72
  • Analyst Decision
  • MYND
  • SNTI Strong Buy
  • Analyst Count
  • MYND 0
  • SNTI 2
  • Target Price
  • MYND N/A
  • SNTI $8.50
  • AVG Volume (30 Days)
  • MYND 93.2K
  • SNTI 138.9K
  • Earning Date
  • MYND 08-27-2025
  • SNTI 11-13-2025
  • Dividend Yield
  • MYND N/A
  • SNTI N/A
  • EPS Growth
  • MYND N/A
  • SNTI N/A
  • EPS
  • MYND N/A
  • SNTI N/A
  • Revenue
  • MYND $209,800,000.00
  • SNTI N/A
  • Revenue This Year
  • MYND N/A
  • SNTI N/A
  • Revenue Next Year
  • MYND N/A
  • SNTI $150.00
  • P/E Ratio
  • MYND N/A
  • SNTI N/A
  • Revenue Growth
  • MYND N/A
  • SNTI N/A
  • 52 Week Low
  • MYND $0.53
  • SNTI $1.26
  • 52 Week High
  • MYND $3.89
  • SNTI $16.94
  • Technical
  • Relative Strength Index (RSI)
  • MYND 57.40
  • SNTI 69.62
  • Support Level
  • MYND $0.90
  • SNTI $1.36
  • Resistance Level
  • MYND $0.98
  • SNTI $1.43
  • Average True Range (ATR)
  • MYND 0.10
  • SNTI 0.09
  • MACD
  • MYND -0.00
  • SNTI 0.04
  • Stochastic Oscillator
  • MYND 41.57
  • SNTI 79.55

About MYND Mynd.ai Inc.

Mynd.ai Inc is a company that provides a platform for delivering digital content in K-12 classrooms, giving teachers seamless connectivity to inspire young minds. It features agnostic hardware that integrates across technology providers. Its product line includes a wide range of interactive tools and technologies, with its award-winning interactive displays at the forefront. It also offers interactive software apps such as Screen Share, computing modules, and accessories that meet the needs of customers, including K -12 educators, colleges and universities, small businesses and corporations, government agencies, and more. Geographically, it operates in United States and Rest of the world.

About SNTI Senti Biosciences Inc.

Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.

Share on Social Networks: